Company intelligence / Profile preview

Docbot

Irvine, California, United Stateshello.docbot.art ↗

Ownership: Private
Development stage: Preclinical

Overview

Docbot’s UltivisionAI™ platform has demonstrated expert-level real-time polyp and lesion detection during colonoscopy, with pivotal multicenter studies underway to validate its impact on adenoma detection rates. The company also published the first study showing deep learning can automatically predict ulcerative colitis severity from endoscopic videos, in collaboration with Eli Lilly.

Therapeutic areas: OncologyGastroenterology
Modalities: DeviceSoftware platform
Industry: Medical Imaging

Partnerships

Eli Lilly and CompanyGastro Health as a clinical trial partner

Beyond the preview

Go deeper on Docbot.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Docbot.

Explore the full profile